Innate Pharma (IPHA)
NASDAQ:IPHA

Innate Pharma (IPHA) Similar Stocks

79 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
AstraZeneca
$242.98B
37.59
17.14%
7 Buy
1 Hold
0 Sell
Strong Buy
$93.61
Merck & Company
$317.26B
139.44
22.16%
14 Buy
2 Hold
0 Sell
Strong Buy
$147.00
Bristol-Myers Squibb
$102.27B
-15.48
-12.82%
4 Buy
9 Hold
2 Sell
Hold
$49.79
GlaxoSmithKline
$81.50B
14.32
15.37%
3 Buy
2 Hold
0 Sell
Moderate Buy
$47.75
Innate Pharma
$186.58M
-21.05
-30.62%
2 Buy
0 Hold
0 Sell
Moderate Buy
$11.50

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
AZN
AstraZeneca
78.13
8.31
11.90%
MRK
Merck & Company
125.26
21.68
20.93%
BMY
Bristol-Myers Squibb
50.45
-8.06
-13.78%
GSK
GlaxoSmithKline
39.86
5.72
16.75%
IPHA
Innate Pharma
2.13
-0.91
-29.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis